Press release - De Gaulle Fleurance & Associés

12/14/21

De Gaulle Fleurance & Associés advises lenders on the financing of a portfolio of solar power plants developed by Photosol

Renewable energies Paris, December 14th, 2021 Photosol has secured a €42.5 million funding for the construction of six photovoltaic power plants in France. This loan was handled by a banking pool com...

12/06/21

De Gaulle Fleurance & Associés assists Banque des Territoires in its acquisition of a stake in FONCIERE ALL IN (All In Tennis Academy)

Real Estate Paris, December 6th, 2021 FONCIERE ALL IN is leading a project to build a high-level tennis training center (All In Tennis Academy) in the Lyon metropolitan area. Previously ...

12/02/21

De Gaulle Fleurance & Associés advises Lysogene for its funding by the BPI

Biotech Paris, December 2nd ,2021 The biopharmaceutical company, Lysogene, has obtained a €4.3 million non-dilutive funding from Bpifrance to support its development. This funding is composed ...

11/29/21

Mohamed El Atfi joins De Gaulle Fleurance EMEA in Abu Dhabi

Paris, November 29th, 2021 Mohamed El Atfi mainly acts in corporate, banking & finance transactions, particularly in Islamic finance, corporate finance, project finance in the Middle East and Af...

11/24/21

De Gaulle Fleurance & Associés assists 4Living Biotech in its partnership with Sanofi aimed at demonstrating the potential clinical efficacy of Mozobil®.

Healthcare Paris, Novembre 24th, 2021 4Living Biotech and Sanofi have recently signed a collaboration agreement aiming at establishing the potential clinical efficacy of Mozobil® as a curative treatm...

11/18/21

Syndicated loan facility for BIOSYNEX : De Gaulle Fleurance & Associés advises La Caisse d’Epargne Grand-Est Europe and other lenders

Healthcare / Syndicated loan facility Paris, novembre 18th, 2021 Rapid diagnostic test manufacturer BIOSYNEX, advised by Natixis Partners Debt Advisory, has announced the signing on November ...